Alloplex Biotherapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.alloplexbio.com
Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies
Phase 1
Completed
- Conditions
- Oncology
- Interventions
- Biological: SUPLEXA
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2024-08-02
- Lead Sponsor
- Alloplex Biotherapeutics Inc
- Target Recruit Count
- 35
- Registration Number
- NCT05237206
- Locations
- 🇦🇺
Greenslopes Private Hospital/Gallipoli Medical Research Foundation, Brisbane, Queeensland, Australia
🇦🇺Cancer Research Sa (Crsa), Adelaide, South Australia, Australia
🇦🇺Southern Oncology Clinical Research Unit (SOCRU), Adelaide, South Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath